Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 60
Gene Symbol: ACTB
ACTB
0.120 GeneticVariation disease BEFREE 7p22.1 microdeletions involving ACTB associated with developmental delay, short stature, and microcephaly. 27633570 2016
Entrez Id: 60
Gene Symbol: ACTB
ACTB
0.120 GeneticVariation disease BEFREE We describe heterozygous ACTB deletions and nonsense and frameshift mutations in 33 individuals with developmental delay, apparent intellectual disability, increased frequency of internal organ malformations (including those of the heart and the renal tract), growth retardation, and a recognizable facial gestalt (interrupted wavy eyebrows, dense eyelashes, wide nose, wide mouth, and a prominent chin) that is distinct from characteristics of individuals with BRWS. 29220674 2017
Entrez Id: 60
Gene Symbol: ACTB
ACTB
0.120 Biomarker disease HPO
Entrez Id: 71
Gene Symbol: ACTG1
ACTG1
0.100 Biomarker disease HPO
Entrez Id: 86
Gene Symbol: ACTL6A
ACTL6A
0.300 Biomarker disease GENOMICS_ENGLAND Heterozygous variants in ACTL6A, encoding a component of the BAF complex, are associated with intellectual disability. 28649782 2017
Entrez Id: 51412
Gene Symbol: ACTL6B
ACTL6B
0.410 GeneticVariation disease BEFREE Pathogenic homozygous variations in ACTL6B cause DECAM syndrome: Developmental delay, Epileptic encephalopathy, Cerebral Atrophy, and abnormal Myelination. 31134736 2019
Entrez Id: 51412
Gene Symbol: ACTL6B
ACTL6B
0.410 Biomarker disease HPO
Entrez Id: 51412
Gene Symbol: ACTL6B
ACTL6B
0.410 CausalMutation disease CLINVAR
Entrez Id: 51412
Gene Symbol: ACTL6B
ACTL6B
0.410 GeneticVariation disease CLINVAR Pathogenic homozygous variations in ACTL6B cause DECAM syndrome: Developmental delay, Epileptic encephalopathy, Cerebral Atrophy, and abnormal Myelination. 31134736 2019
Entrez Id: 51412
Gene Symbol: ACTL6B
ACTL6B
0.410 Biomarker disease GENOMICS_ENGLAND Autozygome and high throughput confirmation of disease genes candidacy. 30237576 2019
Entrez Id: 95
Gene Symbol: ACY1
ACY1
0.110 Biomarker disease HPO
Entrez Id: 95
Gene Symbol: ACY1
ACY1
0.110 Biomarker disease BEFREE The ACY1-deficient individuals were ascertained through urine metabolic screening because of unspecific psychomotor delay (one subject), psychomotor delay with atrophy of the vermis and syringomyelia (one subject), marked muscular hypotonia (one subject), and follow-up for early treated biotinidase deficiency and normal clinical findings (one subject). 16465618 2006
Entrez Id: 11174
Gene Symbol: ADAMTS6
ADAMTS6
0.010 GeneticVariation disease BEFREE Disruption of the ARID1B and ADAMTS6 loci due to a t(5;6)(q12.3;q25.3) in a patient with developmental delay. 25250687 2014
Entrez Id: 9719
Gene Symbol: ADAMTSL2
ADAMTSL2
0.100 Biomarker disease HPO
Entrez Id: 103
Gene Symbol: ADAR
ADAR
0.100 Biomarker disease HPO
Entrez Id: 120
Gene Symbol: ADD3
ADD3
0.100 Biomarker disease HPO
Entrez Id: 577
Gene Symbol: ADGRB3
ADGRB3
0.010 Biomarker disease BEFREE We further discuss the role of ten genes known or assumed to be related to developmental delay and/or autism (BAI3, RIMS1, KCNQ5, HTR1B, PHIP, SYNCRIP, HTR1E, ZNF292, AKIRIN2 and EPHA7). 29904178 2018
Entrez Id: 9289
Gene Symbol: ADGRG1
ADGRG1
0.100 CausalMutation disease CLINVAR
Entrez Id: 9289
Gene Symbol: ADGRG1
ADGRG1
0.100 Biomarker disease HPO
Entrez Id: 132
Gene Symbol: ADK
ADK
0.110 Biomarker disease HPO
Entrez Id: 132
Gene Symbol: ADK
ADK
0.110 Biomarker disease BEFREE We alert clinicians to consider ADK deficiency in any neonate presenting with global developmental delay, hypotonia, dysmorphic features, and high methionine levels. 30477030 2019
Entrez Id: 23394
Gene Symbol: ADNP
ADNP
0.100 Biomarker disease HPO
Entrez Id: 23394
Gene Symbol: ADNP
ADNP
0.100 GeneticVariation disease CLINVAR
Entrez Id: 23394
Gene Symbol: ADNP
ADNP
0.100 CausalMutation disease CLINVAR
Entrez Id: 54936
Gene Symbol: ADPRS
ADPRS
0.010 GeneticVariation disease BEFREE We used exome sequencing to identify five different bi-allelic pathogenic ADPRHL2 variants in 12 individuals from 8 families affected by a neurodegenerative disorder manifesting in childhood or adolescence with key clinical features including developmental delay or regression, seizures, ataxia, and axonal (sensori-)motor neuropathy. 30401461 2018